The Pharma Deal Of The Year Is…
Make a commentBy Ed Silverman // December 24th, 2008 // 7:55 am
• Pharma Blog » Archives
Genentech
Off-Label Avastin Use Tied To Eye Injuries
7 CommentsBy Ed Silverman // December 19th, 2008 // 5:30 pm
Roche Financing For Genentech Deal Looks Tough
5 CommentsBy Ed Silverman // December 1st, 2008 // 7:30 am
UK’s NICE To Lift Ban On Kidney Cancer Meds
1 CommentBy Ed Silverman // December 1st, 2008 // 6:58 am
Roche Scraps $450M Plan To Redevelop Swiss HQ
2 CommentsBy Ed Silverman // November 24th, 2008 // 10:18 am
Pharmalot… Pharmalittle… Good Morning
Make a commentBy Ed Silverman // November 24th, 2008 // 6:41 am
Genentech Disputes Avastin And Blood Clot Risk
1 CommentBy Ed Silverman // November 19th, 2008 // 9:30 am
Pharmalot… Pharmalittle… Morning Edition
Make a commentBy Ed Silverman // November 18th, 2008 // 6:45 am
Pharmalot… Pharmalittle… Good Morning
Make a commentBy Ed Silverman // November 10th, 2008 // 8:00 am
Which Drugmaker Has The Best Oncology PAP?
1 CommentBy Ed Silverman // November 5th, 2008 // 7:22 am